Eczema drug study halted before testing patients
NCT ID NCT05288543
First seen Jan 11, 2026 · Last updated May 08, 2026 · Updated 22 times
Summary
This early-stage study tested a new oral drug called IPG7236 in 63 healthy adults to see if it was safe and how the body processes it. The study was terminated before any results could be gathered. Because it only involved healthy volunteers, it does not provide information on whether the drug works for eczema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scientia Clinical Research Ltd
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.